OR14,84 Twelve months safety and efficacy of LB03002, a new prolonged release formulation of rhGH, as compared to daily rhGH therapy in treatment-naïve children with growth failure due to insufficient secretion of endogenous growth hormone (GHD)
P.H. Saenger, V. Khadilkar, K.A. Radjuk, E. Bolshova, R. Khadgawat, M. El Kholy, V. Peterkova, M. Desai, V. Mericq, C. Savoy, H.-J. Ji, Z. Zadik, J. Kratzsch, M. BidlingmaierVolume:
20
Year:
2010
Language:
english
DOI:
10.1016/s1096-6374(10)70100-3
File:
PDF, 132 KB
english, 2010